pharma

OPPI Annual Summit 2025 Highlights the ‘Power of Partnership’ in Driving India’s Pharma Transformation

The Summit highlights how collaboration, trust, and digital innovation are shaping India's evolution into a global pharma powerhouse committed to…

3 months ago

Axtria Unveils AI-Powered Launch Excellence to Accelerate Success for Emerging Pharma Companies

New integrated offering supports end-to-end brand launches powered by AI, data, and deep industry expertise. BERKELEY HEIGHTS, N.J., Nov. 13,…

3 months ago

Senores Pharma Reports Strong Q2 & H1 FY26 Performance, Sustains Growth Momentum Across Businesses

AHMEDABAD, India, Nov. 7, 2025 /PRNewswire/ -- Senores Pharmaceuticals Limited continued its strong growth trajectory in the second quarter of FY26,…

3 months ago

Anthill Cloud: Transforming Pharma Marketing with AI, Modular Content, and Omnichannel Engagement

COPENHAGEN, Denmark, Nov. 3, 2025 /PRNewswire/ -- Anthill , a leading content excellence and technology partner to the life sciences industry,…

3 months ago

HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead

October 31, 2025 08:00 ET  | Source: HOOKIPA Pharma Inc. NEW YORK and VIENNA, Oct. 31, 2025 (GLOBE NEWSWIRE) --…

3 months ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

September 29, 2025 19:30 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge and London, UK, 30 September 2025 –…

4 months ago

Introducing Auryis AI-Powered Unified Compliance for Pharma & Life Sciences

BENGALURU, India, Aug. 25, 2025 /PRNewswire/ -- Canarys (ISIN: INE0QG301017) is proud to announce the launch of Auryis, their AI-powered, unified compliance…

5 months ago

Advanz Pharma and Alvotech receive European approval for Mynzepli, Biosimilar to Eylea

Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular…

6 months ago

Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial…

6 months ago

Caliber Enters 25th Year of Empowering Global Pharma with GxP Digital Solutions

HYDERABAD, India, Aug. 11, 2025 /PRNewswire/ -- Caliber, a leading global provider of GxP-compliant digital solutions for the life sciences…

6 months ago